Implementation of cancer screening in Europe EU4H-JA-06

The EUCanScreen project aims to implement high-quality screening programs for breast, cervical and colorectal cancer as well as recommended screening tests for lung, prostate and stomach cancer in Europe on a sustainable basis. The aim is to reduce the burden of cancer and improve health equity in the EU. A total of 29 countries are involved, including 25 EU Member States as well as Ukraine, Moldova, Norway and Iceland. The project is coordinated by the University of Latvia. The Center for Evaluation leads the evaluation work package. The purpose of the evaluation is to enable accountability and continuous improvement through data-driven and systematic documentation of achievements, accomplishments, challenges and potential for improvement. The evaluation supports accountability by documenting the implementation of the planned activities, assessing the quality of the results and recording changes in the cancer screening programs of the participating countries. It also optimizes implementation by conducting a strengths-weaknesses-opportunities-risk analysis, implementing continuous feedback processes and documenting lessons learned. The evaluation approach is comprehensive and multi-layered. It includes the evaluation at project level (implementation, quality, cooperation), national level (policies, practices, programmes) and European level (strategies, guidelines, harmonization). In addition, the perspectives of relevant stakeholders and target groups (accessibility, equal opportunities) are included. Methodologically, a combination of qualitative (interviews, document analysis) and quantitative (surveys, monitoring) approaches will be used. Project "Implementation of cancer screening programs (EUCanScreen)", LU registration no. ZD2024/21709, financed by the EU4Health program of the European Union, Grant agreement no. 101162959. Project ID No.: 101162959, Reg. of LU. Nr. ZD2024/21709 Project implementation: 01.06.2024. – 31.05.2028. Total project funding: 38 749 935 EUR List of Participants: Competent Authorities: UNIVERSITY OF LATVIA (LU) GESUNDHEIT OSTERREICH GMBH (AT) SCIENSANO (BE) HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (HR) Ministry of Health of the Republic of Cyprus (CY) USTAV ZDRAVOTNICKYCH INFORMACI A STATISTIKY CESKE REPUBLIKY (CZ) REGION SYDDANMARK (DK) TERVISE ARENGU INSTITUUT (EE) TERVEYDEN JA HYVINVOINNIN LAITOS (FI) INSTITUT NATIONAL DU CANCER GIP (FR) ROBERT KOCH-INSTITUT (DE) MINISTRY OF HEALTH (EL) ORSZAGOS KORANYI PULMONOLOGIAI INTEZET (HU) HEILSUGAESLA HOFUDBORGARSVAEDISINS (IS) DEPARTMENT OF HEALTH (IE) ISTITUTO PER LO STUDIO E LA PREVENZIONE E LA RETE ONCOLOGICA (IT) LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (LT) Ministry for Health and Active Ageing - Government of Malta (MT) INSTITUTIA MEDICO-SANITARA PUBLICA INSTITUTUL ONCOLOGIC (MD) RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL) HELSEDIREKTORATET (NO) NARODOWY INSTYTUT ONKOLOGII IM. MARII SKLODOWSKIEJ-CURIE - PANSTWOWY INSTYTUT BADAWCZY (PL) MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA (PT) INSTITUTUL NATIONAL DE SANATATE PUBLICA (RO) MINISTERSTVO ZDRAVOTNICTVA SLOVENSKEJ REPUBLIKY (SK) ONKOLOSKI INSTITUT LJUBLJANA (SI) INSTITUT CATALA D'ONCOLOGIA (ES) SOCIALSTYRELSEN (SE) STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE (UA) Contact information: Project Coordinator: University of Latvia (Latvijas Universitate) Email: screening@lu.lv www.eucanscreen.eu